Reference
Medicines and Healthcare products Regulatory Agency (UK). Cipaglucosidase alfa with miglustat in the treatment of late-onset Pompe disease Internet Document : 10 Jun 2021. Available from: URL: https://www.gov.uk/government/publications/cipaglucosidase-alfa-with-miglustat-in-the-treatment-of-late-onset-pompe-disease
Rights and permissions
About this article
Cite this article
UK's MHRA approves cipaglucosidase alfa + miglustat for Pompe disease. PharmacoEcon Outcomes News 881, 37 (2021). https://doi.org/10.1007/s40274-021-7833-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7833-6